News | Radiation Therapy | July 19, 2017

Glendale Adventist Medical Center Opens Temporary Radiotherapy Vault

California hospital continues treating patients while upgrading linear accelerator

Glendale Adventist Medical Center Opens Temporary Radiotherapy Vault

July 19, 2017 — RAD Technology Medical Systems announced their most recent project at Glendale Adventist Medical Center in Glendale, Calif.  RAD Technology has provided Glendale Adventist Medical Center (GAMC) with their patented Temporary Radiotherapy Vault (TRV). The TRV will be on site for about 150 days while GAMC renovates their department and upgrades their existing linear accelerator.

GAMC will install a Varian TrueBeam Linear Accelerator, currently scheduled to begin service in Fall 2017. The system is able to destroy cancer cells with more precision and greater accuracy, and often in less time and with fewer treatments.

"We are very excited about the installation of the RAD TRV," said Dennis Quagliani, director of cancer services. "It was important for us to have this temporary facility available while we work on upgrading the cancer center so we do not have to stop or hinder patient care. It will also eliminate the need to send our patients outside of the Glendale area for daily treatments that can extend up to 5-6 weeks. The project couldn't have been easier, as RAD Technology provided full turnkey services, handling everything from start to finish."

In collaboration with hospital administration, RAD Technology managed the permitting, site preparation, installation of the below-grade patented foundation system and electrical service connections. Once those were in place, the company's project team coordinated the delivery of the eight modules comprising the temporary cancer center, assembled the facility in under 10 days and managed the remaining site work to completion.

The TRV is a comprehensive solution that arrives on site and is typically ready to make beam in 5-7 days. It comes fully furnished with a pre-commissioned linear accelerator, reception area, waiting room, office space and restroom.

The TRV offers all the comforts of a permanent facility and is relocatable, according to the company, allowing organizations to use the facility to support their upgrades at multiple locations.

For more information:

Related Content

Videos | Radiation Therapy | February 21, 2019
ITN Associate Editor Jeff Zagoudis speaks with Christy Kesslering, M.D., medical director of radiation oncology at th
FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S.
Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor


News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...